Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA To Pilot Biosimilar Regulatory Science Program
Scheme Will Focus On Advancing Interchangeable Development And Improving Efficiency
Oct 07 2022
•
By
Chloe Kent
The FDA is examining interchangeability as part of the program • Source: Shutterstock
More from Biosimilars
More from Products